Mohawk Industries (MHK) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
18 Jan, 2026Executive summary
Q3 2024 net sales were $2.7B, down 1.7% year-over-year, with adjusted EPS up 7% to $2.90 and net earnings of $162M, reflecting improved productivity, cost controls, and the absence of impairment charges.
Free cash flow reached $204M for the quarter and $443M year-to-date, supporting $450M in capital investments focused on growth, cost reduction, and asset maintenance.
Productivity, restructuring, and cost containment initiatives offset pricing and mix pressures from weak demand and inflation.
Commercial segment outperformed residential, but both faced headwinds from inflation and elevated interest rates.
No impairment charges in 2024, compared to $876M in Q3 2023.
Financial highlights
Q3 2024 adjusted operating income was $240M (8.8% margin), up from $233M (8.4%) in Q3 2023.
Adjusted gross margin: 26.2% vs. 26.6% prior year; reported gross margin: 25.5%.
Adjusted EBITDA for the trailing twelve months was $1.44B; Q3 2024 adjusted EBITDA was $392M (14.4% margin).
Q3 2024 diluted EPS: $2.55 (reported); adjusted EPS: $2.90, up 7% year-over-year.
Net debt at quarter-end was $1.76B, with a net debt to adjusted EBITDA ratio of 1.2x.
Outlook and guidance
Q4 2024 adjusted EPS is projected between $1.77 and $1.87, excluding restructuring or one-time charges.
Recent hurricanes are expected to negatively impact Q4 sales by $25M–$40M, with offsetting benefits from rebuilding in 2025.
Management expects demand to remain weak through year-end, with recovery anticipated in 2025 as interest rates decline and housing markets strengthen.
Long-term demand expected to benefit from pent-up consumer demand, housing shortages, and aging housing stock.
Ongoing restructuring and productivity projects are expected to deliver annual savings of $100M–$115M.
Latest events from Mohawk Industries
- Q2 2026 delivered strong sales, margin gains, and EPS growth, aided by tariff refunds and cost actions.MHK
Q2 2026 - Q1 2026 net sales up 8% to $2.73B, adjusted EPS $1.90, net earnings $117M.MHK
Q1 2026 - Annual meeting covers director elections, pay, new incentive plan, and key governance issues.MHK
Proxy filing - Q4 2025 net sales rose 2.4% with strong cash flow; 2026 outlook expects improved earnings.MHK
Q4 2025 - Proxy covers director elections, auditor ratification, executive pay, and ESG priorities.MHK
Proxy Filing - Q3 2025 sales up 1.4% to $2.8B, with $110M in savings and ongoing cost actions amid soft demand.MHK
Q3 2025 - Q2 adjusted EPS up 9% as cost actions and cash flow offset weak sales and market pressures.MHK
Q2 2024 - Q1 2025 sales and earnings fell, but cost actions and restructuring support future improvement.MHK
Q1 2025 - Adjusted EPS steady at $1.95 as restructuring offsets weak demand; $285M savings targeted.MHK
Q4 2024